Engelsk personkortArnes, Marit
Overingeniør
Medisinsk biologi
Funksjon
Overingeniør
Telefon
776 45403
Epost
Kontor/besøksadresse
Medisin og Helsefag
MH L7.133
Mobil privat
92264423
Alternativ Kontaktinfo
calling: 73-358.
tlf : 776-27454.
Arbeider i CRIStin
- Eggen, Tormod; Sager, Georg; Arnes, Marit; Pettersen, Inger; Ørbo, Anne. Expression of iNOS - A Favourable Prognostic Marker for Early-stage Carcinoma of the Uterine Cervix. Anticancer Research 2011; Volum 31 (6). ISSN 0250-7005.s 2319 - 2325.
- Ørbo, Anne; Arnes, Marit; Pettersen, Inger; Larsen, Kurt; Hanssen, Karin Johanne; Moe, Bjørn Torvald Greve. Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system. Acta Obstetricia et Gynecologica Scandinavica 2010; Volum 89 (11). ISSN 0001-6349.s 1438 - 1446.s doi: 10.3109/00016349.2010.512068.
- Ørbo, Anne; Moe, Bjørn Torvald Greve; Arnes, Marit; Pettersen, Inger; Larsen, Kari Margrethe; Eggen, Tormod; Myrmel, Kristin Smistad; Hanssen, Karin Johanne. Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia. Anticancer Research 2010; Volum 30 (11). ISSN 0250-7005.s 4649 - 4655.
- Ørbo, Anne; Arnes, marit; Hancke, Christine; Vereide, Anne Beate; Pettersen, Inger; Larsen, Kurt. Treatment results of endometrial hyperplasia after prospective D-score classification - A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecologic Oncology 2008; Volum 111. ISSN 0090-8258.s 68 - 73.s doi: 10.1016/j.ygyno.2008.06.014.
- Vereide, Anne Beate; Kaino, Turid; Sager, Georg; Arnes, Marit; Ørbo, Anne. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia. Gynecologic Oncology 2006; Volum 101 (3). ISSN 0090-8258.s 214 - 223.
- Ørbo, Anne; Kaino, Turid; Arnes, Marit; Kopp, Martine; Ecklo, Katrine. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up. Gynecologic Oncology 2004; Volum 95 (1). ISSN 0090-8258.s 82 - 88.
- Ørbo, Anne; Arnesen, Tommy; Arnes, Marit; Straume, Bjørn. Resection margins in conization as prognostic marker for relapse in high-grade dysplasia of the uterine cervix in northern Norway: a retrospective long-term follow-up material. Gynecologic Oncology 2004; Volum 93 (2). ISSN 0090-8258.s 479 - 483.
- Vereide, Anne Beate; Arnes, Marit; Straume, Bjørn; Maltau, Jan Martin; Ørbo, Anne. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecologic Oncology 2004; Volum 91 (3). ISSN 0090-8258.s 526 - 533.
- Ørbo, Anne; Nilsen, Marit Nina; Arnes, Marit; Pettersen, Inger; Pettersen, Kurt. Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia. International Journal of Gynecological Pathology 2003; Volum 22 (2). ISSN 0277-1691.s 141 - 148.
- Ørbo, Anne; Arnes, marit; Pettersen, Inger; Larsen, Kurt; Hanssen, Karin Johanne; Moe, Bjørn Torvald Greve. Successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system coincides with down-regulated progesterone receptor A and B. Virchows Archiv 2011; Volum 459. ISSN 0945-6317.s S256 - S256.
- Ørbo, Anne; Vereide, Anne Beate; Arnes, marit; Pettersen, Inger; Straume, Bjørn. A study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone as treatment for endometrial hyperplasia. Assessment by light microscopy and morphometry. Virchows Archiv 2007; Volum 451. ISSN 0945-6317.s 393 - 394.
